Aphria Inc (APHA) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. APHA received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Aphria Inc also achieved a score of 91 in the Drug Manufacturers - Specialty & Generic industry, putting it above 91 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 134 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Aphria Inc Stock Today?
Aphria Inc (APHA) stock is trading at $4.95 as of 3:24 PM on Wednesday, Nov 4, a drop of -$0.04, or -0.8% from the previous closing price of $4.99. Volume today is 6,836,275 compared to average volume of 7,398,662. The stock has traded between $4.65 and $5.05 so far today.
Click Here to get the full Stock Score Report on Aphria Inc (APHA) Stock.
